Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00180817
Status:
COMPLETED
Last Update Posted:
2022-08-08
First Post:
2005-09-13
Brief Title:
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to see if there are any long term health related issues in women with APA and recurrent miscarriages
Detailed Description:
The association between APA and thrombosis is well documented Both LA and ACA are often detected in individuals with SLE but there is no prospective data on the risk of thrombosis in women who present with recurrent miscarriages in association with APA This study should significantly advance medical knowledge of the natural history of primary antiphospholipid syndrome PAPS which is essential to enable optimal management of relatively young women who may be at risk of complications some of which are potentially life threatening
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None